Author

K. Tuschl

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:imaging· 1 Assay:proteomics· 1 Approach:statistical model· 1 Organism:zebrafish· 1

Frequent Co-Authors

A. Cavedon· 1 shared A. Chakrapani· 1 shared A. Frassetto· 1 shared A. Lubin· 1 shared A. Morris· 1 shared C. A. Hockings· 1 shared C. Böiers· 1 shared C. Clark· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetics

A. Cavedon

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The incidence of movement disorders increases with age and contrasts with subtle and limited neuroimaging abnormalities in argininosuccinic aciduria.

S. Gurung, S. Karamched, D. P. Perocheau, K. Seunarine, T. Balwin, L. Touramanidou, C. Duff, N. Elkhateeb, K. Stepien, R. Sharma, A. Morris, T. Hartley, L. Crowther, S. Grunewald, M. Cleary, , J. Baruteau

This study investigates movement disorders in argininosuccinic aciduria (ASA), finding they increase with age and show specific neuroimaging abnormalities not seen in mouse models.

bioRxiv · Oct 10, 2023 · PreprintGenetics

TLR7 ligation augments haematopoiesis in Rps14 (uS11) deficiency via paradoxical suppression of inflammatory signalling and enhanced differentiation

O. C. Pena, A. Lubin, J. Rowell, C. A. Hockings, Y. Jung, Y. Hoade, P. Dace, L. E. Valdivia, K. Tuschl, C. Böiers, M. C. Virgilio, S. Richardson, E. M. Payne

This study identifies imiquimod, a TLR7 agonist, as a therapeutic for MDS by enhancing haematopoiesis through paradoxical anti-inflammatory effects and increased differentiation.

bioRxiv · Jul 6, 2020Cancer Biology